* Ind-Swift Laboratories received trading approval from BSE and NSE for 81,24,698 equity shares of ₹10 each. * The shares, with distinctive numbers 73486861 to 81611558, were allotted on 25th August, 2025, pursuant to the Scheme of Arrangement for the Amalgamation of Ind-Swift Limited with Ind-Swift Laboratories Limited. * The equity shares are listed and admitted to dealings on the Exchange from December 05, 2025.